Oric Pharmaceuticals (ORIC)CFO sold ~$181K

~$181K

Approx. value · 13K sh @ $13.53

70K

Holds after · shares reported

Traded

Sep 28, 2026

Filed

Sep 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 28, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective July 28, 2026, the Board of Directors (the “Board”) of ORIC Pharmaceuticals, Inc. (the “Company”) approved the ORIC Pharmaceuticals, Inc. Amended and Restated 2022 Inducement Equity Incentive Plan (as amended, the “Inducement Plan”), in order to increase the number of shares reserved for issuance under the Inducement Plan.”
2. Aug 3, 2026Company filing · Form 8-K · ResultsReported its results
3. Sep 24, 2026Insider · 1 personInsiders: 2 sales (~$8K)
4. Sep 28, 2026 · this disclosureInsiderCFO sold ~$181K of ORIC shares in the open market

What came next

1. Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$87K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Oric Pharmaceuticals

For Oric Pharmaceuticals, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ORIC page.

Other recent filings by Dominic Piscitelli, Chief Financial Officer

• SEC Form 4 at Oric Pharmaceuticals (ORIC)Sep 25, 2026
• SEC Form 4 at Oric Pharmaceuticals (ORIC)Sep 25, 2026
• SEC Form 4 at Oric Pharmaceuticals (ORIC)Jul 2, 2025
• SEC Form 4 at Oric Pharmaceuticals (ORIC)Jun 24, 2025
• SEC Form 4 at Oric Pharmaceuticals (ORIC)Jun 24, 2025

The full history of Dominic Piscitelli, Chief Financial Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Oric Pharmaceuticals

• SEC Form 4Oct 2, 2026
• SEC Form 4Oct 2, 2026
• SEC Form 4Sep 25, 2026
• SEC Form 4Sep 25, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its ORIC page.